Lynn Dickey, Ph.D., has an extensive background leading and managing Research and Development activities of cross-functional groups in product and technology development with a focus on plant-made pharmaceuticals. Dr. Dickey was previously the VP of Research and Technology at Biolex Therapeutics, where she oversaw the development of the Lemna plant-based core technology, including genetic engineering, bioanalytics, product development, and design of the aseptic biomanufacturing format.

 

She continued her work with this technology at Synthon Pharmaceuticals, as the VP of R & D and General Manager of the US bioproduction site. Prior to Biolex, Dr. Dickey was a Research Assistant Professor in the Department of Botany at North Carolina State University, where she led research programs focused on the molecular biology of gene expression in transgenic plants.

​